1. bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech
materials. The company’s products and services are designed to benefit people and improve their quality
of life. At the same time Bayer creates value through innovation, growth and high earning power.
The Group is committed to the principles of sustainable development and to its role as a socially and ethically
responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal
rank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35.1 billion. Capital expenditures
amounted to €1.6 billion, R&D expenses to €3.1 billion.
Organization
Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three
service companies operate independently, led by the management holding company. The Corporate Center
supports the Group Management Board in its task of strategic leadership.
Bayer HealthCareBayer CropScienceBayer MaterialScienceBayer Business ServicesBayer Technology ServicesCurrenta
Organization chart with management structure and fields of activity
Download 113 KB
Business operations are the responsibility of the subgroups:
Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical
products. » more
Bayer CropScience, with its highly effective products, pioneering innovations and keen customer focus,
holds global leadership positions in crop protection and non-agricultural pest control.
» more
Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates
and polyurethanes, and innovative system solutions for a wide range of everyday uses. » more
Central service functions are combined into three service companies:
Bayer Business Services is the Bayer Group’s international competence center for it-based services. »
more
Bayer Technology Services is the global technological backbone for the Bayer Group and a major
innovation driver. » more

2. Currenta offers services for the chemical industry including utility supply, waste management,
infrastructure, safety, security, analytics and vocational training. » more
Corporate Governance
Dual governance system with the following governance bodies:
Board of Management: four members, Chairman: Dr. Marijn Dekkers
Supervisory Board: 20 members, Chairman: Dr. Manfred Schneider
Products
The Bayer Group markets some 5,000 products. Best-sellers include:
in the health care field: Betaferon™/Betaseron™, Yasmin™/YAZ™/Yasminelle™, Kogenate™
in the nutrition field: Confidor™/ Gaucho™/Admire™/Merit™, Flint™/Stratego™/Sphere™/Nativo™
in the field of high-tech materials: Makrolon™, Bayblend™, Desmodur™, Desmophen™
Locations
Bayer is represented around the world by about 300 companies*. Global headquarters are in Leverkusen,
Germany.
* fully consolidated subsidiaries (as of Dec. 31, 2010)
Workforce
On December 31, 2010, the Bayer Group had 111.400 employees worldwide (2009: 111.000). In Germany we
had 36.200 employees, who made up 32,5 percent of the Group workforce.
Bayer stock
included in nearly all the major share indices
traded on all German stock exchanges
dividend per share: EUR 1.50
Bayer Group Key Data
Bayer Group 2009 2010 Change
€ million € million %
Sales 31,168 35,088 12,6
EBITDA1 5,815 6,286 8,1
EBITDA before special items 6,472 7,101 9,7
EBIT2 3,006 2,730 -9,2
EBIT before special items 3,772 4,452 18,0
Income before income taxes 1,870 1,721 -8,0
Net income 1,359 1,301 -4,3
Earnings per share (in €)3 1.70 1.57 -7,6
Gross cash flow4 4,658 4,771 2,4
Net cash flow5 5,375 5,773 7,4
Capital expenditures as per segment table 1,669 1,621 -2,9

3. Research and development expenses 2,746 3,053 11,2
Dividend per Bayer AG share (€) 1.40 1.50 7,1
figures restated
1-5 for definition see footnotes to Bayer Group Key Data table
Sales by Segment, (2009 in parentheses)
Members of the Board of Management held offi ces as members of the supervisory board or a comparable
supervising body of the corporations listed (as at July 1, 2011):
Dr. Marijn Dekkers
(born September 22, 1957)
Chairman (effective October 1, 2010)
Member of the Board of Management effective January 1, 2010, appointed until December 31, 2014
Werner Baumann
(born October 6, 1962)
Member of the Board of Management effective January 1, 2010, appointed until December 31, 2012
Bayer Business Services GmbH (Chairman) (effective May 1, 2010)
Bayer CropScience AG (Chairman) (effective May 1, 2010)
Prof. Dr. Wolfgang Plischke
(born September 15, 1951)
Member of the Board of Management effective March 1, 2006, appointed until February 28, 2014
Bayer MaterialScience AG (Chairman)
Bayer Technology Services GmbH (Chairman)
Bayer Innovation GmbH, Shareholders’ Committee (Chairman)
Bayer Real Estate GmbH, Shareholders’ Committee (Chairman)
Dr. Richard Pott
(born May 11, 1953)
Member of the Board of Management effective May 1, 2002, appointed until April 30, 2012
Labor Director
Bayer Chemicals AG (Chairman)
Bayer HealthCare AG (Chairman)
Bayer Pharma AG (Chairman)
Currenta Geschäftsführungs-GmbH (Chairman)
Bayer Innovation GmbH, Shareholders’ Committee